$3.73
0.0250.68%
Last update: Nov 9, 1:36 PM
Fulcrum Therapeutics Inc
FULCNASDAQ
The average analyst price target for Fulcrum Therapeutics is $8, 114.8% above the current price. Of 11 analysts, 3 rate it Buy, 5 Hold and 3 Sell. Targets range from $3 to $24. The latest change came on Jun 3, 2026, when JP Morgan downgraded Fulcrum Therapeutics from Overweight to Underweight.
Price Target Range — 10 Quarters
Analyst Consensus — 11 Analysts
Rating Trend — Last 9 Months
